---
figid: PMC4861839__fphys-07-00168-g0001
figlink: /pmc/articles/PMC4861839/figure/F1/
number: F1
caption: The inositide signaling pathway and target agents used to treat gastric cancer
  and colorectal cancer. Phosphatidylinosityo-4,5-bisphosphate [PtdIns(4,5)P2] is
  converted to phosphatidylinosityo-3,4,5-triphosphate [PtdIns(3,4,5)P3] by phosphoinositide
  3-kinase (PI3K) as a result of phosphorylation. Akt/PKB is recruited to the plasma
  membrane followed by phosphorylation by mammalian target of rapamycin (mTOR) complex2
  and 3-phosphoinositide-dependent protein kinase 1 (PDK1). Inactivation of tuberous
  sclerosis complex (TSC) 2 by Akt leads to degradation of TSC1/TSC2, which permits
  activation of mTOR. mTOR complex 1 phosphorylates downstream substrates S6 kinase
  1(S6K1) and 4E-binding protein 1(4E-BP1), leading to mRNA translation initiation.
  RTK, receptor tyrosine kinase; GPCR, G-protein coupled receptor.
pmcid: PMC4861839
papertitle: The Inositide Signaling Pathway As a Target for Treating Gastric Cancer
  and Colorectal Cancer.
reftext: Hong Jun Kim, et al. Front Physiol. 2016;7:168.
pmc_ranked_result_index: '12863'
pathway_score: 0.9612919
filename: fphys-07-00168-g0001.jpg
figtitle: Inositide signaling pathway and target agents used to treat gastric cancer
  and colorectal cancer
year: '2016'
organisms:
- Homo sapiens
ndex: 97af2249-dedc-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4861839__fphys-07-00168-g0001.html
  '@type': Dataset
  description: The inositide signaling pathway and target agents used to treat gastric
    cancer and colorectal cancer. Phosphatidylinosityo-4,5-bisphosphate [PtdIns(4,5)P2]
    is converted to phosphatidylinosityo-3,4,5-triphosphate [PtdIns(3,4,5)P3] by phosphoinositide
    3-kinase (PI3K) as a result of phosphorylation. Akt/PKB is recruited to the plasma
    membrane followed by phosphorylation by mammalian target of rapamycin (mTOR) complex2
    and 3-phosphoinositide-dependent protein kinase 1 (PDK1). Inactivation of tuberous
    sclerosis complex (TSC) 2 by Akt leads to degradation of TSC1/TSC2, which permits
    activation of mTOR. mTOR complex 1 phosphorylates downstream substrates S6 kinase
    1(S6K1) and 4E-binding protein 1(4E-BP1), leading to mRNA translation initiation.
    RTK, receptor tyrosine kinase; GPCR, G-protein coupled receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MTOR
  - GYPC
  - RPTOR
  - SART3
  - MAPKAP1
  - PIK3R6
  - PIK3R5
  - PDK1
  - PIK3CA
  - PIK3CB
  - AKT2
  - AKT3
  - DLX4
  - TSC1
  - PIK3R4
  - MLST8
  - PIK3CD
  - RICTOR
  - PIK3CG
  - AKT1
  - RPS6KB1
  - TSC2
  - PTEN
  - PIK3R3
  - AKT1S1
  - Perifosine
  - Temsirolimus
  - ridaforolimus
  - NVP-BEZ235
  - AZD8055
  - MK-2206
  - Cancer
genes:
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: GPC
  symbol: GPC
  source: hgnc_alias_symbol
  hgnc_symbol: GYPC
  entrez: '2995'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: (p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: Sin1
  symbol: SIN1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: BP1
  symbol: BP1
  source: hgnc_alias_symbol
  hgnc_symbol: DLX4
  entrez: '1748'
- word: p101)
  symbol: p101
  source: hgnc_alias_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: TSC1
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: RAPTOR
  symbol: raptor
  source: hgnc_alias_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: RICTOR
  symbol: RICTOR
  source: hgnc_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: S6K1
  symbol: S6K1
  source: hgnc_alias_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: TSC2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PRAS40
  symbol: PRAS40
  source: hgnc_alias_symbol
  hgnc_symbol: AKT1S1
  entrez: '84335'
chemicals:
- word: Perifosine
  source: MESH
  identifier: C105905
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: ridaforolimus
  source: MESH
  identifier: C515074
- word: NVP-BEZ235
  source: MESH
  identifier: C531198
- word: AZD8055
  source: MESH
  identifier: C546624
- word: MK-2206
  source: MESH
  identifier: C548887
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC4861839__F1
redirect_from: /figures/PMC4861839__F1
figtype: Figure
---
